section name header

Evidence summaries

Prophylaxis for Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients

Prophylactic use of trimethoprim/sulfamethoxazole decreases the occurrence of Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. PCP-related mortality also appears to decrease. Level of evidence: "A"

A Cochrane review [Abstract] 1 included 13 studies with a total of 1412 subjects (including 520 children) with acute lymphoblastic leukemia and the remaining trials included adults with acute leukemia, solid organ transplantation or autologous bone marrow transplantation. Compared to no treatment or treatment with fluoroquinolones (inactive against Pneumocystis), there was an 85% reduction in the occurrence of PCP in patients receiving prophylaxis with trimethoprim/sulfamethoxazole, RR of 0.15 (95% CI 0.04 to 0.62; 10 trials, 1000 patients). The evidence was graded as moderate due to possible risk of bias. PCP-related mortality was also significantly reduced, RR of 0.17 (95% CI 0.03 to 0.94; nine trials, 886 patients) (low quality of evidence due to possible risk of bias and imprecision), but in trials comparing PCP prophylaxis against placebo or no treatment there was no significant effect on all-cause mortality (low quality of evidence due to imprecision). Occurrence of leukopenia or neutropenia and their duration were not reported consistently. No significant differences in overall adverse events or events requiring discontinuation were seen comparing trimethoprim/sulfamethoxazole to no treatment or placebo (four trials, 470 patients, moderate quality evidence). No differences between once daily versus thrice weekly trimethoprim/sulfamethoxazole were seen (two trials, 207 patients).

Comment: The quality of evidence is downgraded by study quality (inadequate or unclear allocation concealment and inadequate intention-to-treat adherence). The quality of evidence is upgraded by large magnitude of effect.

    References

    • Stern A, Green H, Paul M et al. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 2014;(10):CD005590. [PubMed]

Primary/Secondary Keywords